Koral Shah

Papers

Total Citations

H-Index

About

Koral Shah is a leading urologic oncologist whose research focuses on improving staging accuracy and treatment outcomes in muscle-invasive bladder cancer (MIBC). Her major contributions center on identifying clinical and pathological predictors of pathologic upstaging at radical cystectomy, a critical issue where staging inaccuracies can lead to undertreatment or overtreatment. In her highly cited 2025 study, she systematically evaluated factors driving upstaging, stratifying patients by neoadjuvant chemotherapy receipt—work that directly informs surgical decision-making and risk stratification. Beyond this landmark paper, Shah has advanced the field through investigations into robot-assisted radical cystectomy outcomes and prognostic biomarkers. Her research has garnered significant attention, with her most-cited work accumulating over 100 citations, reflecting its immediate impact on clinical practice. Shah’s findings have been presented at major urology conferences and published in top-tier journals, establishing her as a key voice in precision oncology for bladder cancer. Her ongoing work continues to refine how clinicians predict disease progression and tailor aggressive therapies, making her a vital contributor to improving survival and quality of life for patients with this challenging malignancy.